SCHEMBL3076587

SCHEMBL3076587

COC(C)(C)O[C@H]1C(=O)N(C(=O)OC(C)(C)C)[C@H]1c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.51
ABCB1 P08183 1/20 0.39
KLK7 P49862 6/20 0.38
RORC P51449 2/20 0.37
GPR119 Q8TDV5 1/20 0.36
KLK5 Q9Y337 5/20 0.35
NR1H2 P55055 3/20 0.35
RXRA P19793 2/20 0.35
NR1H3 Q13133 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
BCHE P06276 1/20 0.35
RIPK1 Q13546 2/20 0.34
PRSS1 P07477 2/20 0.34
PRSS2 P07478 2/20 0.34
PRSS3 P35030 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409371 1.00 ELANE (0.51) ELANEABCB1KLK7RORCGPR119
SCHEMBL3076591 1.00 ELANE (0.51) ELANEABCB1KLK7RORCGPR119
SCHEMBL3079099 0.84 ELANE (0.52) ELANEMEN1KMT2ARIPK1
SCHEMBL3075582 0.84 ELANE (0.52) ELANEMEN1KMT2ARIPK1
SCHEMBL5516075 0.84 ELANE (0.52) ELANEMEN1KMT2ARIPK1
SCHEMBL3079101 0.84 ELANE (0.52) ELANEMEN1KMT2ARIPK1
SCHEMBL6860240 0.83 ELANE (0.47) ELANE
SCHEMBL6860243 0.83 ELANE (0.47) ELANE
SCHEMBL7967355 0.82 ELANE (0.53) ELANEABCB1KLK7RORCGPR119
SCHEMBL5963223 0.82 ELANE (0.53) ELANEABCB1KLK7RORCGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050107605-A1 Novel beta-lactams methods for the preparation of taxanes, and sidechain-bearing taxanes BRISTOL-MYERS SQUIBB COMPANY 2005-05-19 US claimed
EP-0617018-B1 Beta-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes BRISTOL MYERS SQUIBB CO (US) 2003-10-01 EP claimed
US-20020137927-A1 Novel beta-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes THOTTATHIL JOHN K (US) 2002-09-26 US claimed
EP-0617018-A1 Beta-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes BRISTOL-MYERS SQUIBB COMPANY (US) 1994-09-28 EP claimed
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-09-09 US disclosed
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-09-09 US disclosed
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-09-09 US disclosed
US-7667055-B2 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-02-23 US disclosed
US-7667055-B2 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-02-23 US disclosed
US-7667055-B2 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2010-02-23 US disclosed
US-7550608-B2 Processes for the preparation of docetaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-23 US disclosed
US-7550608-B2 Processes for the preparation of docetaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-23 US disclosed
US-7541458-B2 β-lactam synthesis FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-7541458-B2 β-lactam synthesis FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-7541458-B2 β-lactam synthesis FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2009-06-02 US disclosed
US-7358378-B2 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-04-15 US disclosed
US-7358378-B2 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-04-15 US disclosed
US-7358378-B2 Processes for the preparation of paclitaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2008-04-15 US disclosed
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed
US-20060281932-A1 Processes for the preparation of docetaxel FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2006-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107605-A1 Novel beta-lactams methods for the preparation of taxanes, and sidechain-bearing taxanes TOP2B, TOP2A, TUBB1 ELANE 1936/4885ABCB1 75/4885KLK7 1098/4885
US-20060281934-A1 Processes for the production of polycyclic fused ring compounds COASY, PARG, PIN4 ELANE 4817/4885ABCB1 2404/4885KLK7 1470/4885
US-20020137927-A1 Novel beta-lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes TOP2A, TOP2B, TUBB1 ELANE 1723/4885ABCB1 130/4885KLK7 1072/4885
US-20100228038-A1 PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS COASY, PARG, PIN4 ELANE 4817/4885ABCB1 2404/4885KLK7 1470/4885
US-20060281932-A1 Processes for the preparation of docetaxel PDCD10, PDS5B, DHCR7 ELANE 4061/4885ABCB1 852/4885KLK7 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.